Cohort ANRS CO6 Primo
Primary HIV-1 infection cohort
Last updated on 20 December 2024
Objectives
- To explore the pathophysiological mechanisms of primary HIV-1 infection,
- To assess the impact of early and prolonged treatment on the long-term prognosis of patients treated from the time of primary infection, particularly in terms of activation/inflammation and reduction of viral reservoirs, and in comparison with uninfected subjects,
- To help document the epidemiology of HIV infection and the prevention of infection in the context of the spread of PrEP,
- Contribute to national recommendations for therapeutic management and evaluate their implementation,
- Use the observational data from the cohort to develop therapeutic trials in primary infection, continue long-term post-trial follow-up and prepare trials aimed at functional cure.
Pathology
VIH-1
Population
Adolescent, Adult
Status
Ongoing
Samples
PBMC, Plasma, Whole blood, Serum
Vous souhaitez accéder aux échantillons biologiques de cette étude
La mise à disposition des échantillons de la biobanque de l’ANRS | Maladies infectieuses émergentes se fait après obtention de l’avis du conseil scientifique de l’étude concernée si elle est en cours, ou après l’obtention de l’avis du directeur de l’ANRS | Maladies infectieuses émergentes si l’étude est terminée.
Pour toute demande d’utilisation, merci de remplir le formulaire ci-dessous et de le transmettre à l’adresse biobanque@anrs.fr
You are participating or have participated in this study
On the form above, you will find information on the ancillary studies for which your data/samples will be or may have been re-used if you gave your consent at the time of inclusion.
If you would like to find out more about your participation in a clinical study, please see the section below
Consult the participants’ area